Showing results (121-130 of 288) with videos related to

Sort By:
Pageof 29
Cancer|March 3, 2007
Prostate-specific antigen velocity and prostate cancer gleason grade and stagePaul F Pinsky, Gerald Andriole, E David Crawford, et al.
The Journal of Urology|September 18, 2009
A framework for the identification of men at increased risk for prostate cancerMonique J Roobol, Fritz H Schröder, E David Crawford, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 16, 2007
Three different strategies for real-time prostate capsule volume computation from 3-D end-fire transrectal ultrasoundAlbaha B Barqawi, Li Lu, E David Crawford, et al.
Cancer|June 29, 2006
The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Current Medical Research and Opinion|March 1, 2014
Cell cycle progression score and treatment decisions in prostate cancer: results from an ongoing registryE David Crawford, Mark C Scholz, Ashok J Kar, et al.
BJU International|March 19, 2016
Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancerNeal D Shore, Franklin Chu, Judd Moul, et al.
The Journal of Urology|July 28, 2011
Methods of developing UWIN, the modified American Urological Association symptom scoreAl B Barqawi, Kathryn F Sullivan, E David Crawford, et al.
Cancer|September 3, 2005
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group studyUlka N Vaishampayan, James R Faulkner, Eric J Small, et al.
Urologic Oncology|February 19, 2017
Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer DatabaseArya Amini, David Raben, E David Crawford, et al.
Cancer|April 4, 2003
Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trialStuart Hinton, Paul J Catalano, Lawrence H Einhorn, et al.
Pageof 29